Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.4
Consolidated Balance Sheets - USD ($)
Oct. 31, 2025
Oct. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,244,000 $ 1,271,000
Short–term investments 13,930,000 18,653,000
Receivables 173,000
Prepaid expenses and other current assets 713,000 1,265,000
Total current assets 15,887,000 21,362,000
Operating lease right-of-use asset 193,000 229,000
Total assets 16,080,000 21,591,000
Current liabilities:    
Accounts payable 165,000 525,000
Accrued expenses 1,761,000 1,946,000
Operating lease liability 41,000 29,000
Total current liabilities 1,967,000 2,500,000
Operating lease liability, non-current 163,000 203,000
Total liabilities 2,130,000 2,703,000
Commitments and contingencies (Note 6)
Equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 33,013,829 and 32,196,862 shares issued and outstanding as of October 31, 2025 and 2024, respectively 330,000 322,000
Additional paid-in capital 266,508,000 260,432,000
Accumulated deficit (251,677,000) (240,750,000)
Treasury stock, 2,000 shares at cost as of October 31, 2024 (6,000)
Total shareholders’ equity 15,161,000 19,998,000
Noncontrolling interest (Note 2) (1,211,000) (1,110,000)
Total equity 13,950,000 18,888,000
Total liabilities and equity 16,080,000 21,591,000
Series A Convertible Preferred Stock [Member]    
Equity:    
Preferred stock, value